CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
-2.22%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$1.07B
AUM Growth
+$5.91M
(+0.55%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
5.91%
Top 10 Holdings %
Top 10 Hldgs %
36.46%
Holding
509
New
13
Increased
172
Reduced
270
Closed
23
Top Buys
| 1 |
Apple
AAPL
|
$12.2M |
| 2 |
Amazon
AMZN
|
$8.41M |
| 3 |
Microsoft
MSFT
|
$6.53M |
| 4 |
Analog Devices
ADI
|
$4.63M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$3.68M |
Top Sells
| 1 |
iShares Silver Trust
SLV
|
$7.9M |
| 2 |
ProShares Ultra Gold
UGL
|
$7.89M |
| 3 |
Arista Networks
ANET
|
$6.7M |
| 4 |
Gilead Sciences
GILD
|
$5.26M |
| 5 |
TSMC
TSM
|
$3.61M |
Sector Composition
| 1 | Technology | 36.93% |
| 2 | Healthcare | 24.36% |
| 3 | Consumer Discretionary | 11.82% |
| 4 | Communication Services | 11.17% |
| 5 | Consumer Staples | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
IQVIA
IQV
$31.9B
| $617K | 0.06% |
3,500
| – | – |
|
227
Applied Optoelectronics
AAOI
$1.5B
| $614K | 0.06% |
40,000
+9,500
| +31% | +$146K |
|
228
Trade Desk
TTD
$25.5B
| $611K | 0.06% |
11,174
+156
| +1% | +$8.54K |
|
229
Scholar Rock
SRRK
$3.02B
| $611K | 0.06% |
18,991
-859
| -4% | -$27.6K |
|
230
TJX Companies
TJX
$155B
| $605K | 0.06% |
4,970
| – | – |
|
231
Li Auto
LI
$24B
| $605K | 0.06% |
24,000
-6,000
| -20% | -$151K |
|
232
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.6B
| $595K | 0.06% |
3,015
+2,343
| +349% | +$463K |
|
233
British American Tobacco
BTI
$122B
| $590K | 0.05% |
+14,004
| New | +$590K |
|
234
Chipotle Mexican Grill
CMG
$55.1B
| $585K | 0.05% |
11,661
-46,644
| -80% | -$2.34M |
|
235
CRISPR Therapeutics
CRSP
$4.99B
| $585K | 0.05% |
17,205
-893
| -5% | -$30.4K |
|
236
Alvotech
ALVO
$2.6B
| $585K | 0.05% |
60,472
+3,896
| +7% | +$37.7K |
|
237
Merus
MRUS
$5.1B
| $583K | 0.05% |
13,858
-659
| -5% | -$27.7K |
|
238
Immunovant
IMVT
$2.99B
| $582K | 0.05% |
34,071
+2,947
| +9% | +$50.4K |
|
239
Legend Biotech
LEGN
$6.66B
| $556K | 0.05% |
16,385
-935
| -5% | -$31.7K |
|
240
Acadia Pharmaceuticals
ACAD
$4.26B
| $556K | 0.05% |
33,455
-1,826
| -5% | -$30.3K |
|
241
Apellis Pharmaceuticals
APLS
$3.55B
| $551K | 0.05% |
25,176
-1,200
| -5% | -$26.2K |
|
242
Constellation Brands
STZ
$26.2B
| $547K | 0.05% |
+2,978
| New | +$547K |
|
243
Ferrari
RACE
$87.1B
| $530K | 0.05% |
1,239
-1,343
| -52% | -$575K |
|
244
CDW
CDW
$22.2B
| $524K | 0.05% |
3,272
+1,103
| +51% | +$177K |
|
245
Amneal Pharmaceuticals
AMRX
$3.02B
| $521K | 0.05% |
62,174
-3,524
| -5% | -$29.5K |
|
246
Xenon Pharmaceuticals
XENE
$3.02B
| $515K | 0.05% |
15,353
-813
| -5% | -$27.3K |
|
247
GlobalFoundries
GFS
$18.5B
| $504K | 0.05% |
13,650
+4,656
| +52% | +$172K |
|
248
Amicus Therapeutics
FOLD
$2.46B
| $503K | 0.05% |
61,627
-1,731
| -3% | -$14.1K |
|
249
Twist Bioscience
TWST
$1.55B
| $470K | 0.04% |
11,965
-621
| -5% | -$24.4K |
|
250
Veracyte
VCYT
$2.55B
| $464K | 0.04% |
15,634
-799
| -5% | -$23.7K |
|